Results 51 to 60 of about 152,693 (210)

Pharmacological management of binge eating disorder [PDF]

Mental Health Clinician
Treatment guidelines for binge eating disorder (BED) lack substantial recommendations for specific pharmacological management beyond lisdexamfetamine. This may lead clinicians to question what other options are available for managing BED.
Andrew M. Williams, PharmD, BCPP, FAAPP
doaj   +1 more source

Stimulants for the Control of Hedonic Appetite

Frontiers in Pharmacology, 2016
The focus of this paper is treatment of obesity in relation to the management of hedonic appetite. Obesity is a complex condition which may be potentiated by excessive reward seeking in combination with executive functioning deficits that impair ...
A. Poulton, E. Hibbert, B. Champion, R. Nanan   +3 more
semanticscholar   +1 more source

Does Dexamphetamine Cause Addiction? A Narrative Review

Psychoactives
Dexamphetamine (DEX) is widely used in treatments, but concerns persist about its potential for addiction. This review aimed to assess the risks of DEX addiction by examining the existing literature.
Hazer Khalifa, Emily J. Hibbert, Natalie Gauci, Alison Poulton   +3 more
doaj   +1 more source

Identification of adrafinil and its main metabolite modafinil in human hair. Self-administration study and interpretation of an authentic case

Forensic Sciences Research, 2020
For several years, the misuse of stimulant substances is increasingly observed both in the field of sport, to improve the functions of the body and therefore to be more performant, and also by non-athletes to make life more tolerable on a daily basis ...
Alice Ameline, Laurie Gheddar, Jean-Sébastien Raul, Pascal Kintz   +3 more
doaj   +1 more source

Opioid Overdoses Increase at Home During the COVID-19 Stay-At-Home Order Period in Cook County, Illinois

AJPM Focus, 2022
Introduction: Stay-at-home orders during the COVID-19 pandemic decreased population mobility to reduce SARS-CoV-2 infection rates. We empirically tested the hypothesis that this public health measure was associated with a higher likelihood of opioid- and
Chris Delcher, PhD, Daniel R. Harris, PhD, Nicholas Anthony, MS, Mojde Mir, MPH   +3 more
doaj   +1 more source

The Stimulation of Growth [PDF]

Science, 1915
n ...
openaire   +3 more sources

Stimulant abuse as a coping strategy—Forensic and criminal consequences of stimulant abuse for neuroenhancement

Frontiers in Public Health, 2022
Pharmacological neuroenhancement (PN) describes the use of divergent psychoactive substances to enhance mental performance (cognition) without medical need. This kind of substance abuse takes place predominantly in stressful situations.
Philipp Dominik, Martin P. Waßmer, Michael Soyka, Andreas G. Franke   +3 more
doaj   +1 more source

What Drives the Non-Medical Use of Stimulants Among College Students? The Role of Self-Efficacy and Attitudes: A Cross-Sectional Study of Israeli Undergraduates

European Journal of Investigation in Health, Psychology and Education
Background: Non-medical use of prescription stimulants is increasing among college students worldwide. While intended for ADHD treatment, many students use these substances to improve their concentration and academic performance. Despite global research,
Keren Dopelt, Shiran Bord, Nourit Houminer-Klepar   +2 more
doaj   +1 more source

Effects of Stimulants on Brain Function in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis

Biological Psychiatry, 2014
Background Psychostimulant medication, most commonly the catecholamine agonist methylphenidate, is the most effective treatment for attention-deficit/hyperactivity disorder (ADHD). However, relatively little is known on the mechanisms of action.
K. Rubia, A. Alegria, A. Cubillo, Anna B. Smith, M. Brammer, Joaquim Radua   +5 more
semanticscholar   +1 more source

Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats

Frontiers in Pharmacology
Co-use of opioids (e.g., fentanyl) and stimulants (e.g., methamphetamine; METH) contributed to >30% of the almost 106,000 fatal overdoses in the United States in 2023.
Jacqueline M. Vazquez, Robert W. Seaman, Drew Caldron, Gregory T. Collins, Gregory T. Collins   +4 more
doaj   +1 more source